Trials / Terminated
TerminatedNCT00468260
The Effects of Patupilone on the Pharmacokinetics and Pharmacodynamics of Warfarin in Patients With Advanced Malignancies
An Open Label Phase I Study to Evaluate the Effects of Patupilone on the Pharmacokinetics and Pharmacodynamics of Warfarin in Patients With Advanced Malignancies-extension Study
- Status
- Terminated
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (estimated)
- Sponsor
- Novartis Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the effects of patupilone on the pharmacokinetics of warfarin in patients with advanced malignancies.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Patupilone |
Timeline
- Start date
- 2007-05-01
- First posted
- 2007-05-02
- Last updated
- 2009-11-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00468260. Inclusion in this directory is not an endorsement.